Ihor Shymanskyy

Ihor Shymanskyy

Auto-generated profile, based on publicly available information

Ihor Shymanskyy

Інститут біохімії ім. О.В. Палладіна НАН України

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
TKTamara Kuchmerovska
Tamara Kuchmerovska
ISIhor Shymanskyy
Ihor Shymanskyy
GDGeorgiy Donchenko
Georgiy Donchenko
MKMykola Kuchmerovskyy
Mykola Kuchmerovskyy
LPLarysa Pakirbaieva
Larysa Pakirbaieva
AKArkadiy Klimenko
Arkadiy Klimenko

1 April 2017 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
OLOlha Lisakovska
Olha Lisakovska
ISIhor Shymanskyy
Ihor Shymanskyy
AMAnna Mazanova
Anna Mazanova
AKAnna Khomenko
Anna Khomenko
MVMykola Veliky
Mykola Veliky
The study was carried out to define whether prednisolone-induced damage to hepatic cells is accompanied by excessive nitric oxide (NO) levels associated with nuclear factor kappa B (NF-κB)/inducible NO synthase (iNOS) activation and evaluate the efficacy of the treatment with vitamin D3. Histopathological examination, activities of liver transaminases (alanine aminotransferase and aspartate aminotransferase), and cell death assays consistently showed that prednisolone (5 mg/kg body weight, 30 days) induces chronic liver injury in female Wistar rats. Specifically, increased hepatocellular necrosis and caspase-3-dependent apoptosis were observed. Prednisolone enhanced iNOS protein expression, NO generation, and tyrosine nitration in liver cells. Despite unchanged hepatic level of the NF-κB/p65 protein, prednisolone increased inhibitory κB-α (IκB-α) degradation, nuclear translocation, and phosphorylation of NF-κB/p65 at Ser311, indicating that NF-κB activation can be involved in the induction of iNOS/NO. All changes were associated with a 2.9-fold decrease in the serum content of 25-hydroxyvitamin D3 and significant reduction of hepatic vitamin D3 receptor (VDR) expression that points reliably to vitamin D3 deficiency and failures in VDR signaling. Vitamin D3 co-administration (100 IU/rat, 30 days) prevented glucocorticoid-evoked abnormalities in hepatic tissue. In conclusion, prednisolone-induced liver disturbances were associated with the impairment of NF-κB/iNOS/NO responses that can be ameliorated by vitamin D3 treatment through VDR-mediated mechanisms.

1 January 2010 in Neurochemistry International
Verified
Journal Article
Closed access
TKTamara Kuchmerovska
Tamara Kuchmerovska
ISIhor Shymanskyy
Ihor Shymanskyy
SCStefan Chlopicki
Stefan Chlopicki
AKArkady Klimenko
Arkady Klimenko

6 February 2018 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
AMAnna Mazanova
Anna Mazanova
ISIhor Shymanskyi
Ihor Shymanskyi
OLOlha Lisakovska
Olha Lisakovska
LHLala Hajiyeva
Lala Hajiyeva
YKYulia Komisarenko
Yulia Komisarenko
MVMykola Veliky
Mykola Veliky
Objectives.Recent prospective studies have found the associations between type 1 diabetes (T1D) and vitamin D deficiency. We investigated the role of vitamin D in the regulation of 25OHD-1α-hydroxylase (CYP27B1) and VDR expression in different tissues of T1D rats.Design.T1D was induced in male Wistar rats by streptozotocin (55 mg/k b.w.). After 2 weeks of T1D, the animals were treated orally with or without vitamin D3(cholecalciferol; 100 IU/rat, 30 days).Methods.Serum 25-hydroxyvitamin D (25OHD) was detected by ELISA. CYP27A1, CYP2R1, CYP27B1, and VDR were assayed by RT-qPCR and Western blotting or visualized by immunofluorescence staining.Results.We demonstrated that T1D led to a decrease in blood 25OHD, which is probably due to the established downregulation of CYP27A1 and CYP2R1 expression. Vitamin D deficiency was accompanied by elevated synthesis of renal CYP27B1 and VDR. Conversely, CYP27B1 and VDR expression decreased in the liver, bone tissue, and bone marrow. Cholecalciferol administration countered the impairments of the vitamin D-endo/para/autocrine system in the kidneys and extrarenal tissues of diabetic rats.Conclusions.T1D-induced vitamin D deficiency is associated with impairments of renal and extrarenal CYP27B1 and VDR expression. Cholecalciferol can be effective in the amelioration of diabetes-associated abnormalities in the vitamin D-endo/para/autocrine system.

31 October 2016 in The Ukrainian Biochemical Journal
Verified
Journal Article
Open access
ISI. O. Shymanskyy
I. O. Shymanskyy
OLOlha Lisakovska
Olha Lisakovska
AMAnna Mazanova
Anna Mazanova
DLD. O. Labudzynskyi
D. O. Labudzynskyi
AKA. V. Khomenko
A. V. Khomenko
MVMykola Veliky
Mykola Veliky
The study was designed to evaluate reactive oxygen species (ROS)/nitric oxide (NO) formation and apoptotic/necrotic cell death elicited by prednisolone in peripheral blood and bone marrow mononuclear cells and to define the efficacy of vitamin D3 to counter glucocorticoid (GC)-induced changes. It was shown that prednisolone (5 mg per kg of female Wistar rat’s body weight for 30 days) evoked ROS and NO overproduction by blood mononuclear cells (monocytes and lymphocytes) that correlated with increased cell apoptosis and necrosis. In contrast, prednisolone did not affect ROS/NO levels in bone marrow mononuclear cells that corresponded to lower level of cell death than in the control. Alterations of prooxidant processes revealed in mononuclear cells and associated with GC action were accompanied by vitamin D3 deficiency in animals, which was assessed by the decreased level of blood serum 25-hydroxivitamin D3 (25OHD3). Vitamin D3 administration (100 IU per rat daily for 30 days, concurrently with prednisolone administration) completely restored 25OHD3 content to the control values and significantly reversed ROS and NO formation in blood mononuclear cells, thus leading to decreased apoptosis. In bone marrow, vitamin D3 activated ROS/NO production and protein nitration that may play a role in prevention of prednisolone-elicited increase in bone resorption. We conclude that vitamin D3 shows a profound protection against GC-associated cellular damage through regulating intracellular ROS/NO formation and cell death pathways.

27 October 2014 in The Ukrainian Biochemical Journal
Verified
Journal Article
Open access
ISI. O. Shymanskyy
I. O. Shymanskyy